FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 118 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,639,000 | -24.4% | 122,300 | -47.5% | 0.00% | -25.0% |
Q4 2018 | $2,167,000 | -6.6% | 233,021 | +39.7% | 0.00% | +33.3% |
Q3 2018 | $2,321,000 | +3.4% | 166,790 | +17.4% | 0.00% | 0.0% |
Q2 2018 | $2,245,000 | +97.6% | 142,030 | +351.9% | 0.00% | +50.0% |
Q1 2017 | $1,136,000 | -65.0% | 31,430 | -51.5% | 0.00% | -60.0% |
Q4 2016 | $3,247,000 | +26.3% | 64,786 | +32.3% | 0.01% | +25.0% |
Q3 2016 | $2,571,000 | +203.2% | 48,986 | +139.0% | 0.00% | +300.0% |
Q2 2016 | $848,000 | +31.3% | 20,492 | -51.2% | 0.00% | 0.0% |
Q3 2015 | $646,000 | -49.9% | 42,000 | -19.1% | 0.00% | -50.0% |
Q2 2015 | $1,289,000 | -45.6% | 51,900 | -50.0% | 0.00% | -50.0% |
Q1 2015 | $2,370,000 | +100.8% | 103,700 | +137.3% | 0.00% | +100.0% |
Q4 2014 | $1,180,000 | – | 43,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |